Stem Cells vs PRP vs Cortisone: Which Regenerative Option Fits Which Problem?

Disclaimer: This article is educational and does not constitute medical advice. Stem cell and PRP therapies discussed here should be evaluated with a licensed physician based on your specific diagnosis and history.

How Cortisone, PRP, and Stem Cell Therapy Actually Work

If you've been living with joint or tendon pain for more than a few months, you've probably heard all three terms thrown around by different providers: cortisone, PRP, and stem cells. They sound like a natural progression — mild to aggressive — but they actually work through completely different mechanisms, and understanding that difference is the key to picking the right one for your situation.

Cortisone (corticosteroid) injections are anti-inflammatory medications injected directly into a joint, tendon sheath, or bursa. They work by suppressing the local inflammatory response — reducing swelling, redness, and the chemical signals that generate pain. Cortisone doesn't rebuild anything; it calms things down.

PRP (platelet-rich plasma) is made by drawing a small amount of your own blood, spinning it in a centrifuge to concentrate the platelets, and injecting that concentrate back into the injured area. Platelets release growth factors that are thought to signal the body's own repair processes — recruiting cells, promoting blood vessel formation, and potentially supporting collagen production in tendons and ligaments.

Stem cell therapy, most often using mesenchymal stem cells (MSCs) harvested from your own bone marrow or fat tissue, aims to introduce cells capable of differentiating into various tissue types and modulating local inflammation. The theory is compelling — but for most orthopedic and joint applications, this remains an investigational, not FDA-approved use, and the actual mechanism of benefit in humans is still being studied.

Cortisone: Fast Relief With a Ceiling

Cortisone remains the most researched and most commonly used of the three, largely because it is inexpensive, widely available, and provides meaningful short-term relief for many patients — often within 48-72 hours.

The tradeoff is durability and long-term joint health. Studies have raised concerns that repeated corticosteroid injections into weight-bearing joints like the knee or hip may be associated with accelerated cartilage volume loss over time. Most physicians now recommend limiting cortisone injections in a single joint to a handful per year, with spacing between injections.

PRP: A Middle Ground With Growing Evidence

PRP occupies an interesting middle ground. It uses your own biological material (autologous), carries a low risk profile similar to any injection, and has a growing body of clinical research — particularly for chronic tendon conditions like tennis elbow, plantar fasciitis, and some knee osteoarthritis presentations.

Results are not universal. Response varies by the specific condition, the concentration and preparation method used, and individual biology. Some patients report meaningful, sustained improvement over 2-3 months; others notice little difference. It typically takes multiple weeks to see benefit, unlike the near-immediate relief cortisone can provide.

"PRP isn't a miracle shot — it's a nudge to your own repair system. Patients who understand that going in tend to have more realistic, and often more satisfying, outcomes." — Dr. Daren Brooks, D.O.

Stem Cell Therapy: Promising Science, Limited Regulatory Approval

Stem cell therapy generates the most headlines and the most hope — and also the most regulatory scrutiny. The FDA has approved stem cell products only for a narrow set of uses, primarily certain blood and immune system disorders treated with hematopoietic stem cells from cord blood. Most orthopedic and joint applications of mesenchymal stem cells remain investigational and are not FDA-approved.

That doesn't mean there's no science behind it — early-stage clinical trials and case series have explored MSCs for knee osteoarthritis, disc degeneration, and tendon injuries, with some encouraging signals. But the evidence base is far less mature than PRP's, sample sizes are often small, and the FDA has specifically warned consumers about clinics making unsubstantiated claims of "curing" arthritis or "regrowing cartilage."

Which Option Fits Which Problem?

There is no single "best" choice — the right option depends on your specific presentation:

• Acute inflammatory flare (a joint that's hot, swollen, and limiting daily function) — cortisone is often the fastest way to calm things down so you can start rehab.
• Chronic tendon pain (tennis elbow, Achilles tendinopathy, plantar fasciitis) that hasn't responded to rest, physical therapy, or bracing — PRP has some of the stronger supporting evidence among regenerative options.
• Mild-to-moderate osteoarthritis where you're trying to delay more invasive intervention — PRP or, in select cases under close physician guidance, mesenchymal stem cell therapy may be considered as part of a broader, individualized plan.
• Someone actively weighing joint replacement or spine surgery — this is a conversation for a physician who can review imaging and history, not a decision to make from a clinic's marketing page.

These regenerative options rarely exist in isolation. At The Bridge Health Recovery Center, we view pain management for conditions like chronic pain and fibromyalgia through a whole-person lens — physical treatment paired with nervous system regulation, since chronic pain often involves a sensitized nervous system that no injection alone can fully address. Our chronic pain recovery program integrates this broader approach.

Questions to Ask Before Choosing a Provider

Whichever option you're considering, ask these before committing:

• What is your specific diagnosis, and is there published evidence supporting this treatment for that diagnosis?
• What preparation method and concentration will be used (for PRP or stem cells), and how is that decided?
• What is the realistic, evidence-based range of outcomes — not the best-case testimonial?
• Is the treatment FDA-approved for this specific use, or is it being offered off-label/investigationally?
• What does follow-up and rehab look like after the injection?

Beyond the Injection: Why the Nervous System Matters

An injection — whichever kind — treats a localized tissue problem. But chronic pain research increasingly shows that persistent pain often involves changes in how the central nervous system processes pain signals, sometimes called central sensitization. This is why some patients get a "successful" procedure on imaging or tissue markers but don't experience proportional pain relief.

This is a central part of what we teach at The Bridge: pain and healing aren't purely mechanical. Programs that pair physical treatment with nervous system regulation, stress management, and whole-person care — like our approach to stress and anxiety alongside physical pain — often see more durable outcomes than any single injection alone.

If you'd like to understand the broader landscape first, our guides on what stem cell therapy is and how it works, whether stem cell therapy is FDA-approved, and what the evidence shows for joint pain go deeper into each piece of this puzzle.

Frequently Asked Questions